ACTH Blocking Peptide for STJ500037 peptide (STJ503625)

SPECIFICATIONS
ImmunogenSynthetic peptide corresponding to ACTH aa 138-176. Sequence: SYSMEHFRWGKPVGKKRRPVKVYPNGAEDESAEAFPLEF
STJ503625-250
🚚 Free UK Delivery on orders over £150
Processing The item has been added
Enquire For Bulk Order
✓ 1-Year Performance Guarantee | SDS & Datasheet Included | Expert Tech Support | Covered by St John's Laboratory Guarantee

General Information

Short DescriptionACTH Blocking Peptide for STJ500037 is synthetically produced from the 138-176 sequence and is suitable for use in western blot applications.
ApplicationsImmunodepletion/Immunocompetition
NoteSTRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.

Product Properties

FormulationLiquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice.
Storage InstructionStore at-20°C for long term storage. Avoid freeze-thaw cycles.

Target Information

ImmunogenSynthetic peptide corresponding to ACTH aa 138-176. Sequence: SYSMEHFRWGKPVGKKRRPVKVYPNGAEDESAEAFPLEF
Immunogen Region138-176
SpecificityThis blocking peptide is recommended for use in combination with ACTH antibody, STJ500037

Additional Info

Background Stimulates adrenal glands and release cortisol.

Information sourced from Uniprot.org

Citations

Product Review

Frequently Asked Questions

Common questions about ACTH Blocking Peptide for STJ500037 peptide (STJ503625)

Well-cited Academic Publications
KO-Validated 700+ Lines
Technical Support Expert Scientific Team
1-Year Guarantee Antibodies & Proteins